![conference banner](/images/conference-banner.jpeg)
Abstract
Synaptic plasticity, or long-term potentiation (LTP), of excitatory synapses in the hippocampus contributes to learning and the establishment of spatial memories. In the CA1 region, induction of LTP enhances the function of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPARs) because of the Ca2+-calmodulin kinase II (CaMKII)-dependent phosphorylation of this subtype of glutamate receptor. Entry of Ca2+, via N-methyl-d-aspartate receptors (NMDARs), during strong synaptic stimulation provides the stimulus to trigger phosphorylation of AMPARs. However, this induction also requires activation of a protein kinase C (PKC)-dependent tyrosine kinase signal cascade and a concomitant upregulation of NMDARs. This review focuses upon NMDARs as potential targets of PKC and / or of the PKC-dependent tyrosine kinase cascade. PKC, acting via the CAK beta / Src tyrosine kinase cascade, enhances NMDAR activation and may increase the number of receptors expressed in synapses. In contras t, direct phosphorylation of NMDARs by PKC increases the sensitivity of NMDA channel inactivation to intracellular Ca2+. In CA1 neurons, PKC provides a point of convergence of control of NMDARs and synaptic plasticity for a wide variety of G-protein coupled and growth factor receptors.
Keywords: PKC-Dependent Kinase Signal, NMDARs, C-terminus cassettes, NMDAR-mediated current, CA1 pyramidal neurons
Current Drug Targets
Title: Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors
Volume: 2 Issue: 3
Author(s): J. F. Macdonald, S. A. Kotecha, W. Y. Lu and M. F. Jackson
Affiliation:
Keywords: PKC-Dependent Kinase Signal, NMDARs, C-terminus cassettes, NMDAR-mediated current, CA1 pyramidal neurons
Abstract: Synaptic plasticity, or long-term potentiation (LTP), of excitatory synapses in the hippocampus contributes to learning and the establishment of spatial memories. In the CA1 region, induction of LTP enhances the function of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPARs) because of the Ca2+-calmodulin kinase II (CaMKII)-dependent phosphorylation of this subtype of glutamate receptor. Entry of Ca2+, via N-methyl-d-aspartate receptors (NMDARs), during strong synaptic stimulation provides the stimulus to trigger phosphorylation of AMPARs. However, this induction also requires activation of a protein kinase C (PKC)-dependent tyrosine kinase signal cascade and a concomitant upregulation of NMDARs. This review focuses upon NMDARs as potential targets of PKC and / or of the PKC-dependent tyrosine kinase cascade. PKC, acting via the CAK beta / Src tyrosine kinase cascade, enhances NMDAR activation and may increase the number of receptors expressed in synapses. In contras t, direct phosphorylation of NMDARs by PKC increases the sensitivity of NMDA channel inactivation to intracellular Ca2+. In CA1 neurons, PKC provides a point of convergence of control of NMDARs and synaptic plasticity for a wide variety of G-protein coupled and growth factor receptors.
Export Options
About this article
Cite this article as:
Macdonald F. J., Kotecha A. S., Lu Y. W. and Jackson F. M., Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors, Current Drug Targets 2001; 2 (3) . https://dx.doi.org/10.2174/1389450013348452
DOI https://dx.doi.org/10.2174/1389450013348452 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response, and/or therapy ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design Silence of the Genes: A Targeted Approach to the Suppression of Specific Genes in Human Disease Using Small Interfering RNA (siRNA)
Current Genomics Chemokines and Malaria Infection
Current Immunology Reviews (Discontinued) Neuroprotective Effect of Resveratrol Against Methamphetamine-Induced Dopaminergic Apoptotic Cell Death in a Cell Culture Model of Neurotoxicity
Current Neuropharmacology A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer’s Disease
Current Pharmaceutical Design Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimers Disease
Current Drug Targets Meet Our Editorial Board Member
Current Neuropharmacology The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Brain Metabolism of Ethanol and Alcoholism: An Update
Current Drug Metabolism Biology of Tenascin C and its Role in Physiology and Pathology
Current Medicinal Chemistry Neuroprotective Activities of Marine Natural Products from Marine Sponges
Current Medicinal Chemistry Novel PSEN1 (P284S) Mutation Causes Alzheimer's Disease with Cerebellar Amyloid β-Protein Deposition
Current Alzheimer Research Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients
Current Alzheimer Research Revolutionizing Pharmaceutical Industry: The Radical Impact of Artificial Intelligence and Machine Learning
Current Pharmaceutical Design Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Central Nervous System Disorders Associated to Immune Checkpoint Inhibitors
Current Cancer Therapy Reviews Perinatal Brain Injury
Current Pediatric Reviews Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Neuroimaging of Narcolepsy
CNS & Neurological Disorders - Drug Targets Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design